-
Product Insights
NewLikelihood of Approval Analysis for Acute Heart Failure
Overview How likely is it that the drugs in Acute Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Heart Failure Overview Acute heart failure (AHF) is a critical...
-
Product Insights
NewLikelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Thematic Analysis
Robotics in Agriculture – Thematic Intelligence
Robotics in Agriculture Thematic Report Overview Robotics will address challenges such as climate change and labor availability aiding the transformation in the future of agriculture. Robots will also support human workers by automating repetitive and strenuous tasks. Robots can also monitor crop health to optimize the application of agricultural inputs and assess readiness for harvesting, reducing food waste, and costs in the process. The Robotics in Agriculture thematic intelligence report gives you an in-depth insight into the robotics market and...
-
Company Insights
Innovation and Patenting activity of OPTiM Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of OPTiM Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Insights
NewMorgan Stanley – Digital Transformation Strategies
Morgan Stanley Digital Transformation Strategies Overview Morgan Stanley is utilizing AI and machine learning to improve its wealth and asset management operations and other operational processes. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of Morgan Stanley was estimated at $4.6 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. Morgan Stanley is utilizing AI...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ANB-10 in Hemophilia A (Factor VIII Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANB-10 in Hemophilia A (Factor VIII Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANB-10 in Hemophilia A (Factor VIII Deficiency) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IQ-DAA in Anthrax
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IQ-DAA in Anthrax report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IQ-DAA in Anthrax Drug Details: IQ-DAA is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-3939 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-3939 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-3939 in Solid Tumor Drug Details: DS-3939 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RO-7297089 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RO-7297089 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RO-7297089 in Relapsed Multiple Myeloma Drug Details: RO-7297089 (AFM-26) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RO-7297089 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RO-7297089 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RO-7297089 in Refractory Multiple Myeloma Drug Details: RO-7297089 (AFM-26) is under...